For Medicare beneficiaries with advanced prostate cancer (PCa), receipt of novel hormonal therapy (NHT) agents varies with race, according to a study published online Dec. 1 in JAMA Network Open…
Read More
Receipt of novel hormonal therapy for advanced prostate cancer varies with race
- Advertisement -
